Diagnostic Value of Sars-Cov-2 Antibody-Based Rapid Diagnostic Test in Paediatric Individuals Clinically Suspected of Covid-19

Authors

  • Arun Bahadur Chand Department of Clinical Laboratory, KIST Medical College and Teaching Hospital, Lalitpur, Nepal https://orcid.org/0000-0002-3021-2886
  • Sohani Bajracharya Department of Microbiology, Kanti Children’s Hospital, Kathmandu, Nepal
  • Isha Amatya Research Section, Nepal Health Research Council, Kathmandu, Kathmandu, Nepal
  • Parbati Gurung Department of Medical Microbiology, Shi-Gan International College of Science and Technology, Kathmandu, Nepal
  • Shila Shrestha Department of Medical Microbiology, Shi-Gan International College of Science and Technology, Kathmandu, Nepal
  • Maina Dulal Department of Medical Microbiology, Shi-Gan International College of Science and Technology, Kathmandu, Nepal
  • Susheela Dahal Department of Medical Microbiology, Shi-Gan International College of Science and Technology, Kathmandu, Nepal
  • Nayanum Pokhrel Department of Microbiology, Kanti Children’s Hospital, Kathmandu, Nepal

DOI:

https://doi.org/10.3126/jmmihs.v10i1.77697

Keywords:

Ab-RDT, clinical features, COVID-19, diagnostic parameters, SARS-CoV-2

Abstract

Introduction: The diagnosis of SARS-CoV-2 infection with quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) has proven challenging in low and middle-income countries, including Nepal, due to its limited availability and higher costs. As such, a simple and cost-effective rapid diagnostic test based on the detection of SARS-CoV-2 antibodies could be an alternative for the diagnosis of individuals with COVID-19.

Method: This study aimed to examine the diagnostic parameters of the SARS-CoV-2 antibody-based rapid diagnostic test (Ab-RDT) as well as the clinical and demographic characteristics of paediatric COVID-19 suspects. The pediatric individuals (<16 years) suspected of COVID-19 who had visited the hospital between January and June 2021 were subjected to the detection of the SARS-CoV-2 genome by qRT-PCR and the induction of antibodies (IgM/IgG) by the National Public Health Laboratory-approved Ab-RDT. The results of the diagnostic tests from the overall individuals and the demographic and clinical details from the individuals confirmed with COVID-19 were collected and analyzed using SPSS version 17.0, with statistical significance considered at p<0.05.

Results: Among the total individuals (n=773), 193(24.98%) tested qRT-PCR-positive and 144(18.63%) tested Ab-RDT-positive. When measured against the gold standard qRT-PCR, Ab-RDT exhibits sensitivity of 74.6%, specificity of 99.7%, positive predictive value of 98.6%, and negative predictive value of 92.2% (p<0.001). Male sex (106/193) (p=0.023), the presence of multiple (≥3) symptoms (73/193) and (≥2) comorbidities (26/193), and a diagnosis of pneumonia (32/193) were identified as possible risk factors for SARS-CoV-2 infection. It seems that the low sensitivity of validated Ab-RDT could only complement qRT-PCR in the detection of SARS-CoV-2 antibodies

Conclusion: It seems that the low sensitivity of validated Ab-RDT could only complement qRT-PCR in the detection of SARS-CoV-2 antibodies

Downloads

Download data is not yet available.
Abstract
180
PDF
99
Cover JMMIHS

Downloads

Published

2025-04-28

How to Cite

Chand, A. B., Bajracharya, S., Amatya, I., Gurung, P., Shrestha, S., Dulal, M., … Pokhrel, N. (2025). Diagnostic Value of Sars-Cov-2 Antibody-Based Rapid Diagnostic Test in Paediatric Individuals Clinically Suspected of Covid-19. Journal of Manmohan Memorial Institute of Health Sciences, 10(1), 18–21. https://doi.org/10.3126/jmmihs.v10i1.77697

Issue

Vol. 10 No. 1 (2025)

Section

Articles

License

Copyright on any research article in JMMIHS is retained by the author(s).
The authors grant JMMIHS a license to publish the article and identify itself as the original publisher.

The corresponding author is responsible for any conflict of interest between authors and others. The journal is not responsible for concepts, ideas, and views reflected in the articles published in the journal. The article will be retracted if any violation of an ethical issue is detected.

The articles in JMMIHS are licensed under a https://creativecommons.org/licenses/by/4.0/  (CC BY).
This license permits use, distribution, and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.